At Hackensack Meridian Health University Medical Center’s John Theurer Cancer Center (JTCC), the Adult Stem Cell transplant ...

Panelists discuss how newly diagnosed head and neck cancer patients should embrace their medical teams, connect with other patients in treatment centers, and remain hopeful about ongoing clinical ...

Panelists discuss how preliminary MICVO data showed promising results with about half of patients with head and neck cancer achieving 30% or more tumor regression, including the patient's complete ...

Panelists discuss how MICVO treatment caused manageable adverse effects, including occasional neuropathy in the patient's left leg that he addresses with compression socks, while he chose to remain in ...

Panelists discuss how MICVO, an antibody-drug conjugate (ADC), works by targeting fibronectin in the tumor microenvironment rather than cancer cells directly, delivering a chemotherapy payload in a ...

Panelists discuss how the patient became a candidate for the MICVO trial after pembrolizumab showed limited progress, with the targeted therapy causing significantly less fatigue while allowing him to ...

Panelists discuss how the patient experienced radiation and chemotherapy treatments with minimal adverse effects, maintaining an active lifestyle throughout, before transitioning to pembrolizumab ...

Panelists discuss how head and neck cancer treatment has evolved to include combined therapeutic approaches using surgery, radiation, chemotherapy with cisplatin, and newer immunotherapies, such as ...

Going through breast cancer has pushed me to do things I never thought I would. A significant part of that newfound freedom comes from the influence of a famous icon and fellow breast cancer survivor, ...

Davis, who is 30 years old, is the mother of a 16-month-old son and works as a pediatric emergency room nurse at Hackensack ...

“Myelofibrosis therapy today is still limited to the four JAK inhibitors,” he noted. These FDA-approved therapies include Jakafi (ruxolitinib), Inrebic (fedratinib), Vonjo (pacritinib), and Ojjaara ...

Molecular testing helps distinguish kidney cancer subtypes, ensuring patients get accurate diagnoses and treatment plans, ...